Medicare Advantage, Interqual update, and provider enrollment changes in September 2023

Featured story: School restart: Helping kids adjust to a new morning routine

Even if your kids have a reason to get up early over summer break — whether it’s getting dropped off at day camp or going to a friend’s house — it’s a fact that summer tends to include much less structure than they have during the school year. The Centers for Disease Control and Prevention note that children and teens who don’t get enough sleep are at higher risk for problems with attention, as well as more mental health issues, yet nearly 60% of middle-school students and over 72% of high-school students don’t get enough sleep on school nights.

iStock-1390625309

Continue reading

 

In this issue:

  • Medicare Advantage annual election period
  • Interqual update
  • Join our quality program committee to help improve the quality and effectiveness of our care
  • Continuity of care-Mass General Brigham ACO
  • Provider enrollment changes
  • Mass General Brigham Health Plan’s Drug fee schedules to be updated
  • Medical policy updates
  • Formulary updates
  • Code updates
  • Drug code updates

Medicare Advantage annual election period

Reminder: the annual election period for Medicare Advantage runs from October 15 through December 7. Please update your directory info and for more information visit massgeneralbrighamhealthplan.org/providers/medicare-advantage

Hours changing

Effective 9/25, provider services will begin closing at 4:30 PM, Monday through Friday. Also, you may experience longer than normal wait times. As a reminder the online portal contains information on the following and is available 24 hours a day 7 days a week:

•Verify patient eligibility 
•Verify claims status 
•Submit or check authorizations/referrals
•Access your explanation of payments (EOPs)
•View member and provider roster reports
•Update your practice information 

If you do not have access to Our Provider Portal, you can register at: massgeneralbrighamhealthplan.org/providers/portal

Interqual update
 

In September Mass General Brigham Health Plan will be moving to the 2023 InterQual Criteria for all products. Effective 10/01/2023 you will be required to provide a diagnosis code in the Provider Portal to ensure timely processing of authorization requests without having to call for more information.

Home care authorizations
    • Current day authorization is continuously revised. Which requires IT assistance.
    • Going forward Home Care authorizations will be restricted to a 1 year date span.

Portal enhancements for Peer to Peer (P2P) requests and authorization closure legend

To improve the in-network provider experience for P2P requests, we've added a new enhancement to the provider portal for these requests.

Things to keep in mind for P2P requests on our provider portal:

    • Do not enter P2P requests on this site for vendors such as CVS Caremark/Novologix or eviCore. For these go directly to the vendor for P2P/appeal
    • These can only be requested for a medical necessity denial
    • P2P request must be made within 30 days of the date on the denial letter

Any request not meeting the criteria above will be closed.

In addition, an authorization closure legend has been added to all user guides for the most frequently used authorization closure reasons. This feature has been added to provide clarification around closure reasons.


Join our quality program committee to help improve the quality and effectiveness of our care

Mass General Brigham Health Plan is seeking provider membership (including all MD specialties, NPs, and PAs) for its Quality Program Committee (QPC) to share expertise on topics that will ensure the quality and effectiveness of the care delivered to its members. Committee members have the opportunity to weigh in on a variety of health plan topics including:

  • Network adequacy;
  • Utilization Management and Medical Necessity Procedures;
  • Member experience and satisfaction;
  • Identifying and addressing potential health care disparities and inequities.

The QPC meets virtually on the third Wednesday every other month for 90 minutes. 

The meeting dates for the rest of 2023 are:

  • Wednesday, October 18th 7:30 a.m.-9:00 a.m.
  • Wednesday, December 20th 7:30-9:00 a.m.

If you are interested in joining the QPC, please contact Elaine Alden at Ealden@allwayshealth.org indicating your interest and we will reach out with information on the next steps regarding your participation.  Some providers may qualify to earn $300 per meeting.  Please feel free to contact us with any questions regarding your eligibility for this and/or any other questions that you may have about the Committee.

We appreciate the opportunity to collaborate with our provider network and thank you for the care you provide our members.


Continuity of care-Mass General Brigham ACO

Our continuity of care (CoC) period through 8/31/23 for the Mass General Brigham ACO, has now ended.

As a reminder, in the event of active ongoing services with an OON provider, after 8/31/23, the provider must submit the request for continued service via our Mass General Brigham Health Plan Provider Portal. If the current authorization with the in network provider has expired (past 8/31/23), and the member still requires the service, then the provider will need to submit a request for prior authorization. These are considered a new request for services and not Continuity of Care as the previously approved services auth has ended and will be reviewed by our Utilization Management Team.

Here's what providers should know:

  • Please ensure prior authorizations (PA) are submitted with all required documentation for all services that require PA. For more info, click here 
  • Members will need prior authorization to see specialists out of network. See our provider directory for more information.
  • Prior authorizations should be submitted via our provider portal 

For more information and tools regarding the MGB ACO please visit: Mass General Brigham ACO | Mass General Brigham Health Plan

For questions, contact our Provider Service Center at 855-444-4647 or via email at healthplanproviderservice@mgb.org


Provider enrollment changes

The Centers for Medicare & Medicaid Services and other regulatory bodies, as well as the federal No Surprises Act of 2021, require health plans to maintain and update data in provider directories. We rely on providers to review their data and notify us of changes as they happen, this ensures members have access to accurate information.

Provider demographic information in our Provider Directory must reflect accurate data at all times and should mirror the information members may receive directly from the practice or via patient appointment call centers.

To keep accurate network provider information, Mass General Brigham Health Plan must be promptly notified in writing of relevant changes pertaining to a provider’s practice. The primary way to notify Mass General Brigham Health Plan of enrollment changes is through the Provider Enrollment Portal within the Mass General Brigham Health Plan Provider Portal https://provider.massgeneralbrighamhealthplan.org/Authentication/LogIn?ReturnUrl=%2F.

The Provider Enrollment Portal gives you easy access to submit requests such as the following:

  • Enroll a new provider into your group
  • Terminate an existing provider from your group
  • Open and close your panels
  • Submit demographic changes
  • Generate a complete HCAS form

The Provider Enrollment Portal gives you real-time status information on your enrollment request as well as sends you an email notification when your request has been completed.

Providers can also submit provider enrollment changes via the following tools:

In addition, please keep the following in mind:

  • Practice location — As new providers join your practice, it is important that only practice locations where the provider regularly administers direct patient care are submitted for inclusion in the Mass General Brigham Health Plan provider directory. Locations in which a provider may occasionally render indirect care — such as interpretation of tests or inpatient-only care — should be specified to ensure the location information is included in the provider’s demographic profile, but not in the provider directory.
  • Timely notice — As a reminder, notification of address, acceptance of new patients, provider terminations, and other demographic information changes should be submitted at least 30 days in advance.

For questions, contact our Provider Service Center at 855-444-4647 or HealthPlanProvidersService@mgb.org


A message for OT/PT/ST providers in the ACO network

Reminder: Prior Authorization (PA) is required for therapy services Please visit PA requirements page for more information:  Authorization guidelines | Mass General Brigham Health Plan


Mass General Brigham Health Plan’s Drug fee schedules to be updated

Mass General Brigham Health Plan reviews its drug fee schedules quarterly to ensure that they are current, comprehensive and consistent with industry standards, to the extent supported by its systems. In most cases, changes involve adding fees for new or existing codes, to supplement the fees already on the fee schedule.

The next update will occur on October 1, 2023. Changes may involve both new and existing CPT and HCPCS codes, and will include the planned quarterly update to physician administered drugs, immune globulin, vaccine and toxoid fees.


Medical policy updates

Four medical policies were reviewed and passed by the Mass General Brigham Health Plan’s Medical Policy Committee. These policies are now posted to MassGeneralBrighamHealthPlan.org. The table below is a summary.

For more information or to download our medical policies, go to https://www.massgeneralbrighamhealthplan.org/providers/medical-policies and select the policy under the medical policy listings.

 

Medical Policies

Policy Title

Summary

Products Affected

Effective Date

Hemgenix

[NEW POLICY]

Effective Date: Guidelines to determine the medical necessity for Hemgenix for the treatment of patients with Hemophilia B (congenital Factor IX deficiency).

Commercial and Medicare Advantage

8/1/2023

Specialty Medication Administration – Site of Care

September 2023: Annual Review. Medicare language added. References updated.

Commercial and Connector/Qualified Health Plans

9/1/2023

Outpatient Drug Screening and Testing

September 2023: Annual update. Medicare Advantage added to table. Medicare Variation language added. References updated

All products

9/1/2023

Non-Emergency Medically Necessary Transportation

September 2023: Annual update. Medicare Advantage added to table 1. Medicare Variation language added. References updated.

All products

9/1/2023

 

In addition, as of August 2023, Mass General Brigham Health Plan customized InterQual criteria and published new guidelines. The following criteria was customized and created:

  1. Reduction Mammoplasty, Male (MassHealth) (Custom) – MGB

This customization was done to distinguish the criteria after adopting recent MassHealth updated Medical Necessity Guidelines.

Also, Mass General Brigham Health Plan customized InterQual criteria and published a new guideline.

  1. CP: Imaging. The guidelines are called Imaging, Knee (Custom) - MGB

To access this criteria, providers should log in to Mass General Brigham Health Plan’s provider website at MassGeneralBrighamHealthPlan.org and click the InterQual® Criteria Lookup link under the Resources Menu.


Code updates

The following service(s) are covered with prior authorization required for Commercial/ASO and Medicare Advantage Plans:

Code

Description

Effective Date: *Note the effective date applies to the code and not the drug

J0174

Injection, lecanemab-irmb, 1 mg

07/06/2023

 

The following service(s) are covered with prior authorization required for Commercial/ASO and Medicare Advantage Plans; Not reimbursable for MGB ACO Plans:

Code

Description

Effective Date

J9029

Injection, nadofaragene firadenovec-vncg, per therapeutic dose

07/01/2023

 

The following service(s) are covered with no prior authorization required for Medicare Advantage Plans:

Code

Description

Effective Date

27279

Arthrodesis, sacroiliac joint, percutaneous or minimally invasive (indirect visualization), with image guidance, includes obtaining bone graft when performed, and placement of transfixing device

08/01/2023

C9150

Xenon xe-129 hyperpolarized gas, diagnostic, per study dose

07/01/2023

C9784

Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components

07/01/2023

C9785

Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components

07/01/2023

C9786

Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report

07/01/2023

C9787

Gastric electrophysiology mapping with simultaneous patient symptom profiling

07/01/2023

Q4272

Esano a, per square centimeter

07/01/2023

Q4273

Esano aaa, per square centimeter

07/01/2023

Q4274

Esano ac, per square centimeter

07/01/2023

Q4275

Esano aca, per square centimeter

07/01/2023

Q4276

Orion, per square centimeter

07/01/2023

Q4277

Woundplus membrane or e-graft, per square centimeter

07/01/2023

Q4278

Epieffect, per square centimeter

07/01/2023

Q4280

Xcell amnio matrix, per square centimeter

07/01/2023

Q4281

Barrera sl or barrera dl, per square centimeter

07/01/2023

Q4282

Cygnus dual, per square centimeter

07/01/2023

Q4283

Biovance tri-layer or biovance 3l, per square centimeter

07/01/2023

Q4284

Dermabind sl, per square centimeter

07/01/2023

E0711

Upper extremity medical tubing/lines enclosure or covering device, restricts elbow range of motion

04/01/2023

 

The following service(s) are covered when prior authorized for MGB ACO Plans:

Code

Description

Effective Date

33289

Transcatheter implantation of wireless pulmonary artery pressure sensor for long-term hemodynamic monitoring, including deployment and calibration of the sensor, right heart catheterization, selective pulmonary catheterization, radiological supervision and interpretation, and pulmonary artery angiography, when performed

01/01/2023


Formulary Updates

 

DEFINITIONS

Formulary                      These drugs are included in Mass General Brigham’s covered drug list.

 

Non-Formulary             These drugs are not included in Mass General Brigham’s formulary. The plan would only cover formulary alternatives. Providers can request Non-Formulary drugs as an exception, and the plan would require trial of all appropriate formulary alternatives prior to approving coverage of a Non-Formulary drug. If a Non-Formulary drug is approved, the member’s cost sharing would be the highest tier.

 

Preferred                        These drugs are on Mass General Brigham’s formulary and offer a lower cost to members.

 

Non-Preferred              These drugs are on Mass General Brigham’s formulary but offer a higher cost to members.

 

Excluded                         Mass General Brigham does not cover these drugs. Members will receive a denial for all Excluded drug requests.

 

Updates for Commercial Members

Effective 11/01/2023

The following changes are being made to the listed medications:

Rezurock           

This drug will require prior authorization.

 

Updates for MassHealth Members

The following changes are being made to the listed medications to be in compliance with the MassHealth UPPL (Unified Pharmacy Product List):

Effective ASAP

Opioid Dependence and Reversal Agents

Over-the-counter Naloxone has been added to the pharmacy benefit as covered.

 

 

Effective 10/01/2023

Pharmaceutical Compounding

Program

 

 

Reminder that Mass General Brigham Health Plan will align with the MassHealth Compounding Program no later than 10/01/2023.

*Please note, individual drug PA criteria must be met first in order for approval of a compound*

The following will require a prior authorization for compounded pharmaceutical products (with the exception of infusion, intravenous, intravenous piggyback, intravenous push, and subcutaneous routes of administration):

·       With a total cost of greater than or equal to $100

·       With topical route of administration

 

Effective 11/01/2023

 

Lymepak

Valsartan Solution

 

The following medications have been added to the pharmacy benefit with prior authorization required and added to the federal rebate program.

 

Metformin ER 625 mg tablet

 

The following medications will remain on the pharmacy benefit with prior authorization and added to the federal rebate program.

Amzeeq

Zilxi

The following medications have been added to the pharmacy benefit with prior authorization and removed from the federal rebate program.

 

Exelderm

Ximino

 

The following medications will remain on the pharmacy benefit with prior authorization and removed from the federal rebate program.

 

Opioid Dependence and Reversal Agents

 

LifEMS was added to the pharmacy benefit with prior authorization and quantity limit of 2 kits per 365 days.